Citation Impact
Citing Papers
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional Radiology
2013
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
1991 Standout
Dietary Fiber, Glycemic Load, and Risk of Non—insulin-dependent Diabetes Mellitus in Women
1997 Standout
Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies
1992
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
2017
The Native Kidney Biopsy
2015
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
2012
Acute Eosinophilic and Neutrophilic Pneumonia following Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for Hepatocellular Carcinoma: A Case Report
2014
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
2016
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2018 Standout
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
2016
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
2014
Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres
2005
Palmitate stimulates glucose transport in rat adipocytes by a mechanism involving translocation of the insulin sensitive glucose transporter (GLUT4)
1991
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2012 Standout
The molecular basis of blood coagulation
1988 Standout
Hepatocellular carcinoma
2021 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
2012
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Purification and characterization of a human recombinant T-cell protein-tyrosine-phosphatase from a baculovirus expression system
1991 StandoutNobel
Vascular disorders of the liver # †
2008 Standout
Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis
1994 StandoutScienceNobel
All ras proteins are polyisoprenylated but only some are palmitoylated
1989 Standout
Transarterial radioembolizationvschemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis
2016
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
2010
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
2016
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
2016
Remodelling the extracellular matrix in development and disease
2014 Standout
Transarterial therapies for hepatocellular carcinoma
2011
Loco‐regional treatment of hepatocellular carcinoma†
2010
Management of HCC
2012
Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
2011
Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT–pathologic correlation in 178 liver explants
2013
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2017
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma
2014
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
2013
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Treatment of intermediate-stage hepatocellular carcinoma
2014
Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine
1988
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
2017
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
2009
Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review
2014
Fatty acylation of proteins
1989
Acute Budd–Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt
2004
Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery
2014
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Hepatocellular Carcinoma
2011 Standout
Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies
2012
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion
2015
[12] Expression of G-protein a subunits in Escherichia coli
1994 StandoutNobel
Chronic Kidney Disease
2016 Standout
Fatty Acylation of Proteins
1988
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome
2004
Hepatocellular carcinoma
2022 Standout
Budd–Chiari syndrome: Long‐term effect on outcome with transjugular intrahepatic portosystemic shunt
2005
Targeted Therapies for Hepatocellular Carcinoma
2011
Lipid Modulation of Insulin Receptor Tyrosine Kinase Activity in Cultured Cells, Animals, and Reconstituted Systems a
1993
Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.
1988
Local and Regional Therapies for Hepatocellular Carcinoma
2020
Palmitoylation of the human β2-adrenergic receptor
1989 StandoutNobel
A rapid posttranslational myristylation of a 68-kD protein in D. discoideum.
1990
Fatty acylation promotes fusion of transport vesicles with Golgi cisternae.
1990 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma
2013
A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization
2017
Purification and characterization of Go alpha and three types of Gi alpha after expression in Escherichia coli.
1990 StandoutNobel
Purification and characterization of recombinant G16 alpha from Sf9 cells: activation of purified phospholipase C isozymes by G-protein alpha subunits.
1993 StandoutNobel
G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells.
1990 StandoutNobel
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Two distinct populations of ARF bound to Golgi membranes.
1993 StandoutNobel
The Whole Structure of the 13-Subunit Oxidized Cytochrome c Oxidase at 2.8 Å
1996 StandoutScience
Lipid modifications of G protein subunits.
1991 StandoutNobel
Palmitoylation Increases the Kinase Activity of the G Protein-Coupled Receptor Kinase, GRK6
1998 StandoutNobel
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Transarterial Chemoembolization and Radioembolization
2014
Acylation of viral and eukaryotic proteins
1989
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid modification diversity in the GRK family.
1994 StandoutNobel
Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation
1991 StandoutNobel
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
2016
Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex.
1992 StandoutNobel
Cytochrome c oxidase in Neurospora crassa contains myristic acid covalently linked to subunit 1.
1995
Molecular biology of the Rh antigens
1991 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Purification and characterization of smooth muscle cell caveolae.
1994 StandoutNobel
Global cancer statistics, 2012
2015 Standout
Inhibition of Adenylyl Cyclase by G iα
1993 StandoutScienceNobel
Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse
2001 Standout
Lipid modifications of G proteins: alpha subunits are palmitoylated.
1993 StandoutNobel
Metabolic radiolabeling techniques for identification of prenylated and fatty acylated proteins
1990
Receptor regulation of G-protein palmitoylation.
1994 StandoutNobel
Diversity of G Proteins in Signal Transduction
1991 StandoutScience
G protein gamma subunits contain a 20-carbon isoprenoid.
1990 StandoutNobel
Map-Based Cloning of a Protein Kinase Gene Conferring Disease Resistance in Tomato
1993 StandoutScience
Works of A. Watkinson being referenced
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
2009
TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
2003
Transjugular kidney biopsy
2004
Evolutionary origins of neuropeptides, hormones, and receptors: possible applications to immunology
1985
Myristyl and palmityl acylation of the insulin receptor.
1987